Consenso - Associação Brasileira de Alergia e Imunopatologia

56 Rev. bras. alerg. imunopatol. – Vol. 29, Nº 1, 2006 Consenso
Lumry WR. A review of the preclinical and clinical data of
81.
intranasal steroids used in the treatment of allergic
newer
J Allergy Clin Immunol 1999;104:150-8.
rhinitis.
Lund VJ, Black JH, Szabo LZ, Schrewelius C, Akerlund A. Effi-
82.
and tolerability of budesonide aqueous nasal spray in
cacy
rhinosinusitis patients. Rhinology 2004; 42: 57-62.
chronic
Malm L, Anggard A. Vasoconstrictors. in: Mygind, N, Naclerio
83.
(ed). Allergic and Non-Allergic Rhinitis. Clinical Aspects.
RM
Munksgaard, 1993; 95-100.
Copenhagen:
Maynard LM, Ernst ME. Leukotriene Receptor Antagonists in
84.
treatment of Allergic Rhinitis. Ann Pharmacother 2001;
the
35:1274-7.
Mello Jr JF, Mion O. Rinite Alérgica. In: Campos, C. A. H.;
85.
HOO. Tratado de Otorrinolaringologia. Editora Roca.
Costa,
p. 68-81.
2003;
Meltzer EO, Hamilos DL, Hadley JA, Lanza DC, Marple BF,
86.
RA et al.Rhinosinusitis: Establishing definitions for
Nicklas
research and patient care. J Allergy Clin Immunol
clinical
114: S155-S212.
2004;
Meltzer EO, Orgel HA, Jalowayski AA. Histamine levels and
87.
cytology in children with chronic otitis media and
nasal
Ann Allergy Asthma Immunol 1995; 74: 406-10.
rhinitis.
Meltzer EO. Clinical evidence for antileukotriene therapy in
88.
management of allergic rhinitis. Ann Allergy Asthma Im-
the
2002; 88: 23 -9.
munol
Menon AD, Stamm AC. In: Microcirurgia Nasosinusal. Stamm
89.
Rio de janeiro: Editora Revista Ltda, 1995.
AC.
Micheletto C, Tognella S, Visconti M, Pomari C, Trevisan F,
90.
Negro RW. Montelukast 10mg improves nasal function
Del
nasal response to aspirin in ASA sensitive asthmatics: a
and
study versus placebo. Allergy 2004; 59: 289-94.
controlled
Miyake MAM. Rinossinusopatia Alérgica. In: Stamm AC. Mi-
91.
Nasossinusal. Rio de Janeiro: Revinter 1995; 129-
crocirurgia
138.
Moller C, Dreborg S, Ferdousi HA, Halken S, Host A, Jacobsen
92.
al. Pollen immunotherapy reduces the development of
L,et
in children with seasonal rhinocon-junctivitis (the
asthma
J Allergy Clin Immunol 2002;109: 251-6.
PAT-study).
Moloney JR, Collins J. Nasal Polyps and Bronchial Asthma. Br
93.
AlIergy Dis Chest 1997; 71:1.
J
Moneret-Valtrin DA, Shieh V, Wayoff M. Non-Allergic Rhinitis
94.
Eosinophilia Syndrome (NARES) - A Precursor of the
with
Ann Allergy 1990; 64: 513-18.
Triad.
Montealegre F, Meyer B, Chardon D, Vargas W, Zavala D,
95.
B, et al. Comparative prevalence of sensitization to
Hart
animal, plant and mould allergens in subjects with
common
or atopic dermatitis and/or allergic rhinitis living in a
asthma,
environment Clin Exp Allergy. 2004 Jan;34(1):51-8.
tropical
Murray JJ, Nathan RA, Bronsky EA, Olufade AO, Chapman D,
96.
B. Comprehensive evaluation of cetirizine in the ma-
Kramer
of seasonal allergic rhinitis: impact on symptoms,
nagement
of life, productivity, and activity impairment. Allergy
quality
Proc 2002; 23: 391-8.
Asthma
Naclerio R, Rosenwasser L, Ohkubo K. Allergic rhinitis: cur-
97.
and future treatments. Clin Exp Allergy Rev 2002; 2:
rent
137-147.
Naspitz CK, Solé D, Jacob CA, Sarinho E, Soares FJ, Dantas V
98.
al. Sensitization to inhalant and food allergens in Brazilian
et
children by in vitro total and specific IgE assay. J Pe-
atopic
(Rio J) 2004; 80: 203-10.
diatr
Nassar J, Anselmo-Lima WT. Participação das variações ana-
99.
do complexo ostiomeatal analisadas por tomografia
tômicas
Rev Bras ORL 2001; 67: 489-95.
computadorizada.
Nayak A. A review of montelukast in the treatment of asthma
100.
allergic rhinitis. Expert Opin Pharmacother 2004; 5: 679-
and
686.
Nelson HS. Advances in upper airway diseases and allergen
101.
J Allergy Clin Immunol 2004; 113: 635-42.
immunotherapy.
Nelson HS. Immunotherapy: 1999-2004. J Allergy Clin Im-
102.
2004; 113: 1013-23.
munol
Ng KH, Chong D, Wong CK, Ong HT, Lee CY, Lee BW et al.
103.
nervous system side effects of first and second gene-
Central
antihistamines in school children with perennial allergic
ration
a randomized, double-blind, placebo-controlled com-
rhinitis:
study. Pediatrics 2004; 113: 116-21.
parative
Nguyen LH, Manoukian JJ, Sobol SE, Tewfik Tl, Mazer BD,
104.
MD et al. Similar allergic inflammation in the middle
Schloss
and the upper airway: evidence linking otitis media with
ear
to the united airways concept. J Allergy Clin Immu-
effusion
2004; 114: 1110-5.
nol.
Nickel R, Illi S, Lau S, Sommerfeld C, Bergmann R, Kamin W,
105.
al. Variability of total serum immunoglobulin E levels from
et
to the age of 10 years. A prospective evaluation in a
birth
birth cohort (German Multicenter Allergy Study) Clin
large
Allergy 2005; 35: 619-23.
Exp
Norjavaara E, De Verdier MG. Normal pregnancy outcomes in
106.
population-based study including 2,968 pregnant women
a
to budesonide. J Allergy Clin Immunol 2003; 111:
exposed
42. 736-
Norman P.S. Sublingual swallow immunotherapy in the new
107.
Ann Allergy Asthma Immunol 2004; 93: 405-6.
world.
Nunes ICC, Solé D, Pastorino AC, Melo K, Gonzáles C, Wan-
108.
N, et al. Prevalence of asthma, rhino-conjunctivitis,
dalsen
atopic eczema among schoolchildren living in the state of
and
Paulo, Brazil - ISAAC phase III. J Allergy Clin Immunol
São
113: S284.
2004;
Oldenbeuving NB, Kleinjan A, Mulder PG, Lumley P, Groot EJ,
109.
CM et al. Evaluation of an intranasal house dust mite
Drunen
model as a tool in clinical research. Allergy 2005;
provocation
751-9.
60:
Passáli D, Moesges R, Hassen HA, Belussi, L. International
110.
on Allergic- Rhinitis in Childhood. Allergy 1999:
Conference
(suppl. 55): 10.
54
Pawankar R. Exploring the role of leukotriene receptor anta-
111.
in the management of allergic rhinitis and comorbid
gonists
Clin Exp All Rev 2003; 3: 74-80
asthma.
Pelikan Z, Pelikan-Filipek M. Role of nasal allergy in chronic
112.
sinusitis – diagnostic value of nasal challenge with
maxillary
J Allergy Clin Immunol 1990; 86:484-91.
allergen.
Penard-Morand C, Charpin D, Raherison C, Kopferschmitt C,
113.
D, Lavaud F et al. Long-term exposure to back-
Caillaud
air pollution related to respiratory and allergic health
ground
schoolchildren. Clin Exp Allergy. 2005; 35: 1279-87.
in
Perry TT, Corren J, Philip G, Kim EH, Conover-Walker MK,
114.
MP et al. Protective effect of montelukast on lower and
Malice
respiratory tract responses to short-term cat allergen
upper
Ann Allergy Asthma Immunol 2004; 93: 431-8.
exposure.
Platts-Mills TAE. The Role of Allergens in Allergic Disease. J
115.
Clin Immunol 1998; 101: S364-66.
Allergy
Plaut M, Valentine MD. Clinical practice. Allergic rhinitis. N
116.
J Med. 2005 Nov 3;353(18):1934-44
Engl
Plewako H, Arvidsson M, Petruson K. The effect of omalizu-
117.
on nasal allergic inflammation. J Allergy Clin Immunol
mab
110: 68-71.
2002;
Ponikau JU, Sherris DA, Kephart GM, Kern EB, Gaffey TA,
118.
JE, et al. Features of airway remodeling and eosi-
Tarara
inflammation in chronic rhinosinusitis: is the histonophilic
similar to asthma? J Allergy Clin Immunol. 2003;
pathology
112:877-82.
Poole MD. A focus on acute sinusitis in adults: changes in
119.
management. Am J Med 1999; 106: 385-475.
disease
Potter PC, Van Niekerk CH, Schoeman HS. Effects of triam-
120.
on quality of life in patients with persistent allergic
cinolone
Ann Allergy Asthma Immunol 2003; 91: 368-74.
rhinitis.
Potter PC. Levocetirizine is effective for symptom relief
121.
nasal congestion in adolescent and adult (PAR)
including
to house dust mites. Allergy 2003; 58: 893-9.
sensitized
Practice parameters for allergen immunotherapy. Joint Task
122.
on Practice Parameters, representing the American
Force
of Allergy, Asthma and Immunology, the American
Academy
of Allergy, Asthma and Immunology, and the Joint
College
of Allergy, Asthma and Immunology. J Allergy Clin
Council
1996; 98 (6 Pt 1): 1001-1011.
Immunol
Prescott CA. Nasal Obstruction in Infancy. Arch Dis Child
123.
72: 287-9.
1995;
Quraishi MS, Jones NS, Mason J. The rheology of nasal mu-
124.
a review. Clin Otolaryngol 1998; 23: 403-13.
cus:
Rachelefsky GS. National guidelines needed to manage rhini-
125.
and prevent complications. Ann Allergy Asthma Immunol
tis
Mar; 82:296-305.
1999
Rak S, Jacobson MR, Sudderick RM. Influence of pro-longed
126.
with topical corticosteroid (fluticasone propionate)
treatment
early and late nasal responses and celular in-filtration in
on
nasal mucosa after allergen challenge. Clin Exp Allergy
the
24: 930-9.
1994;
Ramadan HH, Fornelli R, Ortiz AO, Rodman S. Correlation of
127.
and severity of sinus disease. Am J Rhinol 1999; 12:
allergy
345-7.
Ricketti AJ. Allergic rhinitis. In: Grammer LC, Greenberger PA
128.
Patterson’s Allergic Disease, 6 (ed), th
Philadelphia, Pen-
ed,
nsyllvania, Lippincott Williams & Wilkins, 2002, p.159-182.